What is Denis Chem Lab Ltd (537536) share price return in the past 10 years?

Denis Chem Lab Ltd share price has declined -1.8% annually (CAGR) over the past ten years.

What is the share price of Denis Chem Lab Ltd (537536)?

Company share prices are keep on changing according to the market conditions. The current trading price of Denis Chem Lab Ltd (537536) on 05-Jun-2026 10:57:00 at 10:57 is 70.81.

What is the P/E ratio of Denis Chem Lab?

The latest standalone P/E ratio of Denis Chem Lab as of 05-Jun-2026 is 11.77.

What is the P/B ratio of Denis Chem Lab Ltd (537536)?

The latest standalone P/B ratio of Denis Chem Lab Ltd (537536) as of 05-Jun-2026 is 1.08.

What is the 52-week high and low of Denis Chem Lab Ltd (537536)?

The 52-week high of Denis Chem Lab Ltd (537536) is Rs. 109.25 and the 52-week low is Rs. 56.10.

Denis Chem Lab Ltd (537536) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Denis Chem Lab Ltd (537536)
Brand: Denis Chem Lab

Denis Chem Lab Ltd (537536)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537536 NSE: Pharmaceuticals & Drugs | Small Cap | Denis Chem Lab Share Price

Denis Chem Lab Ltd (537536)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537536 NSE: Pharmaceuticals & Drugs | Small Cap | Denis Chem Lab Share Price

Key Metrics

Valuation Multiples

Market Cap

₹99 Cr.

Current Price

₹70.8

52-Week Low / High

₹56 / 109

TTM EPS

₹6.1

TTM Sales

₹182 Cr.

Book Value per Share

₹66

P/E Ratio

11.77

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

1.08

Lower than its 5-year historical median

Price to Sales (P/S)

0.54

Lower than its 5-year historical median

EV/EBITDA

3.79

Lower than its 5-year historical median

Dividend Yield

1.62%

Profitability Efficiency

Return on Equity (ROE)

9.76%

Outperforms industry median

Return on Capital Employed (ROCE)

13.89%

Outperforms industry median

Return on Assets (ROA)

7.29%

Operating Profit Margin

9.3%

Net Profit Margin

4.66%

Gross Profit Margin

10.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

3.27%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-24.12%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-27.6%

Asset Quality

Promoter Holding

38.98%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹78 Cr.

Equity

₹13.9 Cr.

Face Value

₹10

All Time Low / High

₹16.26 / 232.90

Denis Chem Lab stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Denis Chem Lab Ltd a good quality company?

Denis Chem Lab Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Denis Chem Lab Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Denis Chem Lab Ltd vs industry peers?

Denis Chem Lab Ltd revenue CAGR is 4.94%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Denis Chem Lab Ltd?

Promoters hold 38.98% of the Denis Chem Lab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Denis Chem Lab Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -2.2% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	5.3%	12.2%	9.4%	11.9%	11.3%	6.5%	13.8%	16.1%	20.2%	13.9%	-
Value Creation Index ⓘ	-0.6	-0.1	-0.3	-0.2	-0.2	-0.5	0.0	0.2	0.4	0.0	-
Growth Parameters ⓘ
Sales ⓘ	99.6	113	107	124	136	109	137	161	168	173	182
Sales YoY Gr.	-	13.8%	-5.4%	15.8%	9.7%	-19.7%	24.9%	17.8%	4.3%	3.3%	-
Adj EPS ⓘ	-4.7	0.9	1.6	4.1	3	1.6	4.5	5.7	8	5.8	6.1
YoY Gr.	-	NA	80.2%	149.4%	-25.9%	-45.9%	174.4%	25.8%	42.1%	-27.7%	-
BVPS (₹) ⓘ	13	24.1	36	40.7	42.6	44.3	47.9	52.1	57.9	61.3	66
Adj Net Profit ⓘ	-4.5	1.1	2.3	5.7	4.2	2.3	6.3	7.9	11.2	8.1	8
Cash Flow from Ops. ⓘ	20.9	6.8	10.6	8	13.4	8	17.1	16.3	17.8	12.1	-
Debt/CF from Ops. ⓘ	2.1	5.5	2.4	2.9	1	1.1	0.2	0.1	0.1	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6.3%	4.9%	8.3%	3.3%
Adj EPS ⓘ	NA	13.9%	8.9%	-27.7%
BVPSⓘ	18.8%	7.6%	8.6%	5.9%
Share Price	-1.8%	1.2%	-3.3%	-33.4%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-27	4.9	5.7	10.7	7.3	3.8	9.8	11.3	14.6	9.8	9.5
Op. Profit Mgn % ⓘ	8.5	12.3	11.4	11.2	11	9.4	10.5	11.7	12.7	9.3	9.7
Net Profit Mgn % ⓘ	-4.5	1	2.1	4.6	3.1	2.1	4.6	4.9	6.7	4.7	4.6
Debt to Equity ⓘ	3.5	1.3	0.5	0.4	0.2	0.1	0.1	0	0	0	0
Working Cap Days ⓘ	122	114	146	139	131	157	123	103	99	98	81
Cash Conv. Cycle ⓘ	46	24	36	53	66	80	59	44	40	37	49

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	99.64	113.36	107.22	124.14	136.15	109.32	136.56	160.85	167.82	173.30
Operating Expenses ⓘ +	91.16	99.47	95.17	110.26	121.15	99.06	122.21	142.07	146.59	157.19
Manufacturing Costs	8.28	9.68	9.92	11.15	14.10	10.28	12.31	15.32	15.39	15.15
Material Costs	52.13	53.44	48.90	61.19	61.57	55.43	72.34	84.46	86.86	95.77
Employee Cost	9.43	12.56	9.47	12.46	12.20	10.59	11.74	13.03	14.39	15.26
Other Costs ⓘ	21.32	23.78	26.88	25.47	33.28	22.76	25.81	29.26	29.94	31.01
Operating Profit ⓘ	8.48	13.89	12.05	13.87	15	10.25	14.35	18.78	21.23	16.11
Operating Profit Margin (%)	8.5%	12.3%	11.2%	11.2%	11.0%	9.4%	10.5%	11.7%	12.7%	9.3%
Other Income ⓘ +	0.47	0.65	0.53	1.66	0.28	0.35	1.05	0.59	1.39	2.37
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	6.73	5.80	4.61	3.25	2.89	1.55	0.76	0.64	0.54	0.51
Depreciation ⓘ	5.64	6.77	5.93	6.36	6.66	5.96	5.76	7.82	6.95	6.86
Profit Before Tax ⓘ	-3.42	1.97	2.04	5.92	5.73	3.09	8.88	10.92	15.13	11.11
Tax ⓘ	1.03	0.73	-0.10	-0.43	1.51	0.82	2.62	3.06	3.98	3.04
Profit After Tax	-4.45	1.24	2.14	6.35	4.21	2.26	6.26	7.86	11.16	8.08
PAT Margin (%)	-4.5%	1.1%	2.0%	5.1%	3.1%	2.1%	4.6%	4.9%	6.7%	4.7%
Adjusted EPS (₹)	-4.7	1.0	1.5	4.6	3.0	1.6	4.5	5.7	8.0	5.8
Dividend Payout Ratio (%)	0%	0%	0%	21.90%	0%	46%	33.20%	35.30%	31.10%	25.80%

Valuation of Denis Chem Lab - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	12.40	29.86	49.93	56.46	59.09	61.50	66.45	72.26	80.37	85.10
Share Capital ⓘ	9.04	11.74	13.88	13.88	13.88	13.88	13.88	13.88	13.88	13.88
Reserves ⓘ	3.36	18.12	36.06	42.58	45.21	47.63	52.57	58.39	66.49	71.23
Debt +	36.25	33.13	21.08	18.98	10.51	8.19	2.24	0.95	0.59	0.82
Long Term Debt	19.96	17.25	8.51	4.80	2.17	3.50	2.18	0.92	0.45	0.45
Short Term Debt	16.29	15.87	12.57	14.18	8.34	4.69	0.06	0.03	0.14	0.37
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	16.96	19.95	20.27	17.09	18.25	15.67	19.70	18.28	21.41	21.24
Others Liabilities ⓘ	19.15	11.16	9.72	13.08	9.57	6.90	8	7.95	6.99	5.11
Total Liabilities ⓘ	84.76	94.10	101	105.61	97.42	92.26	96.39	99.45	109.35	112.27
Fixed Assets
Net Fixed Assets ⓘ +	39.68	44.27	39.68	50.42	45.84	41.39	41.66	35.42	37.62	38.82
Gross Block	62.16	73.52	74.67	91.88	93.96	95.19	100.62	102.19	111.34	119.40
Accumulated Depreciation	22.48	29.25	34.99	41.46	48.12	53.79	58.96	66.77	73.72	80.58
CWIP ⓘ	9.84	0.67	5.20	0.04	0	0.08	0	2.13	0.22	0.07
Investments ⓘ	0.06	0.06	0.06	0	0	0	0	0	0	0
Inventories	5.52	5.18	7.11	8.42	8.53	9.11	9.89	9.12	10.19	9.81
Trade Receivables	22.68	31.86	30.79	35.95	34.98	32.88	31.84	31.24	31.66	30.61
Cash Equivalents	2.82	7.41	11.15	5.67	3.63	4.54	8.83	16.93	25.15	26.23
Others Assets ⓘ	4.14	4.66	7	5.11	4.43	4.27	4.17	4.61	4.51	6.72
Total Assets ⓘ	84.76	94.10	101	105.61	97.42	92.26	96.39	99.45	109.35	112.27

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	20.89	6.77	10.62	7.97	13.37	7.97	17.07	16.34	17.81	12.09
PBT ⓘ	-3.42	1.97	2.04	5.92	5.73	3.09	8.88	10.92	15.13	11.11
Adjustment ⓘ	12.61	12.15	10.39	8.36	9.32	7.20	5.91	8.04	5.84	5.71
Changes in Working Capital ⓘ	11.66	-7.3	-1.33	-5.31	0.08	-1.59	3.36	-0.22	1.18	0.16
Tax Paid ⓘ	0.04	-0.04	-0.48	-1	-1.75	-0.72	-1.08	-2.39	-4.34	-4.89
Cash Flow From Investing Activity ⓘ +	-12.90	-1.30	-16.05	-1.78	-1.98	-1.13	-10.14	-11.15	-14.89	-8.23
Capex	-12.67	-2.18	-8.34	-8.52	-2.19	-1.73	-5.39	-4.70	-6.93	-7.63
Net Investments	0	0.61	-8.12	6.36	-0.02	0.42	-4.94	-6.92	-9.03	-1.43
Others ⓘ	-0.23	0.26	0.41	0.38	0.22	0.18	0.19	0.47	1.06	0.83
Cash Flow From Financing Activity ⓘ +	-6.98	-0.28	1.05	-5.37	-13.90	-5.51	-7.20	-4.01	-4.21	-4.21
Net Proceeds from Shares ⓘ	0	16.20	17.93	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-4.07	-6.62	-12.27	-3.72	-3.49	-0.30	-1.33	-1.26	-0.47	0
Interest Paid ⓘ	-6.73	-5.80	-4.61	-3.25	-2.89	-1.55	-0.76	-0.64	-0.54	-0.51
Dividend Paid ⓘ	-0.01	0	0	0	-1.68	0	-1.04	-2.08	-2.78	-3.47
Others ⓘ	3.83	-4.05	-0	1.61	-5.84	-3.65	-4.08	-0.03	-0.42	-0.23
Net Cash Flow ⓘ	1.01	5.19	-4.38	0.82	-2.51	1.33	-0.27	1.18	-1.29	-0.34

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-30.41	5.86	5.37	11.94	7.29	3.76	9.79	11.33	14.62	9.76
ROCE (%)	5.3	12.19	9.37	11.9	11.34	6.5	13.79	16.07	20.15	13.89
Asset Turnover Ratio	1.25	1.32	1.11	1.2	1.34	1.15	1.45	1.64	1.61	1.56
PAT to CFO Conversion(x)	N/A	5.46	4.96	1.26	3.18	3.53	2.73	2.08	1.6	1.5
Working Capital Days
Receivable Days	84.50	84.30	105.60	98.10	95.10	113.30	86.50	71.60	68.40	65.60
Inventory Days	16.70	16.50	20.70	22.80	22.70	29.50	25.40	21.60	21	21.10
Payable Days	87.80	126.10	150.10	111.40	104.70	111.70	89.20	82.10	83.40	81.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Denis Chem Lab Ltd FAQs

The current trading price of Denis Chem Lab on 05-Jun-2026 10:57 is ₹70.81.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Denis Chem Lab stood at ₹98.97 Cr

The latest P/E ratio of Denis Chem Lab as of 04-Jun-2026 is 11.77.

The latest P/B ratio of Denis Chem Lab as of 04-Jun-2026 is 1.08.

The 52-week high of Denis Chem Lab is ₹109.2 and the 52-week low is ₹56.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Denis Chem Lab is ₹182 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Denis Chem Lab Ltd is a average quality company.

The key valuation ratios of Denis Chem Lab Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Denis Chem Lab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Denis Chem Lab Ltd

Denis Chem Lab is a Public Limited Pharmaceutical Company incorporated in 1982. It started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years it has been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. It Manufactures and market sterile Intravenous injectibles in Both Glass and Plastic Bottles.

The company’s manufacturing facilities are located in a pollution free environment near Ahmedabad, Gujarat. The Manufacturing facilities are located on a land area of about 14000 sq. metres, the built up area for the manufacturing operations is about 7000 sq.m.

Its manufacturing facilities have been approved by the Foods and Drugs Control Administration Authority (FDCA), Gujarat & WHO GMP. It has also been approved by international bodies, includes FDCA Ivory Cost, Ministry of Health-Vietnam, Ministry of Health-Combodia.

Business area of the company

The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company’s product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands.

Denis Chem Lab Ltd (537536)

Denis Chem Lab Ltd (537536)

Denis Chem Lab stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Denis Chem Lab - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Denis Chem Lab Ltd FAQs

About Denis Chem Lab Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Denis Chem Lab Ltd (537536)

Denis Chem Lab Ltd (537536)

Denis Chem Lab stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Denis Chem Lab - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Denis Chem Lab Ltd FAQs

What is the share price of Denis Chem Lab?

What is the market cap of Denis Chem Lab?

What is the P/E ratio of Denis Chem Lab?

What is the P/B ratio of Denis Chem Lab?

What is the 52-week high and low of Denis Chem Lab?

What is the TTM revenue of Denis Chem Lab?

Is Denis Chem Lab Ltd a good quality company?

Is Denis Chem Lab Ltd undervalued or overvalued?

Is Denis Chem Lab Ltd a good buy now?

About Denis Chem Lab Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.